At the end of the latest market close, Happiness Biotech Group Limited (HAPP) was valued at $1.83. In that particular session, Stock kicked-off at the price of $2.13 while reaching the peak value of $2.54 and lowest value recorded on the day was $1.95. The stock current value is $2.12.
Recently in News on January 11, 2021, Happiness Biotech’s E-Commerce Business – Happy Buy, Achieved Over 70% Growth in December. Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that Happy Buy, the Company’s wholly-owned subsidiary focusing on e-commerce business, has achieved over 70% growth in December 2020, on a month-on-month basis. The total sales of Happy Buy in December has reached over $5.5 million compared with approximately $3 million in November. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Happiness Biotech Group Limited had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.54 on 01/11/21, with the lowest value was $1.66 for the same time period, recorded on 01/04/21.
Happiness Biotech Group Limited (HAPP) full year performance was -52.59%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Happiness Biotech Group Limited shares are logging -65.03% during the 52-week period from high price, and 30.06% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.63 and $6.06.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 26914500 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Happiness Biotech Group Limited (HAPP) recorded performance in the market was 15.22%, having the revenues showcasing 17.78% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 53.76M, as it employees total of 179 workers.
Specialists analysis on Happiness Biotech Group Limited (HAPP)
During the last month, 0 analysts gave the Happiness Biotech Group Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.88, with a change in the price was noted -0.18. In a similar fashion, Happiness Biotech Group Limited posted a movement of -7.83% for the period of last 100 days, recording 780,583 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HAPP is recording 0.04 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Happiness Biotech Group Limited (HAPP)
Raw Stochastic average of Happiness Biotech Group Limited in the period of last 50 days is set at 53.85%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.27%. In the last 20 days, the company’s Stochastic %K was 33.55% and its Stochastic %D was recorded 24.09%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 15.22%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -19.19%, alongside a downfall of -52.59% for the period of the last 12 months. The shares increased approximately by 25.44% in the 7-day charts and went up by 12.17% in the period of the last 30 days. Common stock shares were driven by 17.78% during last recorded quarter.